1. 944PQUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset. (23rd October 2018) Authors: Moore, K N; Secord, A A; Geller, M; Miller, D S; Cloven, N G; Fleming, G F; Wahner Hendrickson, A E; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; Berek, J S; Chan, J K; Rimel, B J; Li, Y; Luptakova, K; Clark, R; Matulonis, U A; Monk, B J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗